Filing Details

Accession Number:
0001181431-10-027001
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-14 13:00:00
Reporting Period:
2010-05-12
Filing Date:
2010-05-14
Accepted Time:
2010-05-14 16:29:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1043218 E Jonathan Rothschild C/O Immucell Corp
56 Evergreen Drive
Portland ME 04103
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-12 400 $3.51 459,370 No 4 P Direct
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-12 100 $3.49 459,470 No 4 P Direct
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-12 225 $3.50 459,695 No 4 P Direct
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-12 900 $3.54 460,595 No 4 P Direct
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-13 255 $3.51 460,850 No 4 P Direct
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-12 600 $3.55 461,450 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.
  2. This figure includes 213,855 shares of common stock held by Arterio, Inc., a company solely owned by Mr. Rothschild.